#United States #Houston #Echolight #Mike Yuja #REMS

Echolight Appoints Mike Yuja as Chief Commercial Officer

Echolight, a pioneering company in the field of bone densitometry, recently made a significant leadership change by appointing Mike Yuja as the new Chief Commercial Officer and General Manager for North America. This exciting announcement was made on January 6, 2025, and highlights Echolight's commitment to enhancing its market presence and operational effectiveness in the US.

A Leader with Vast Experience

Mike Yuja brings over 20 years of diverse experience to this role, with expertise spanning various sectors, including diagnostic imaging, pharmaceuticals, and AI-based imaging software. Throughout his career, Mike has held prominent positions that have allowed him to lead cross-functional teams in sales, marketing, operations, and customer service. His prior experience includes senior leadership roles at well-known companies such as Mallinckrodt, Covidien, and Jubilant Radiopharma, where he successfully drove business initiatives and achieved significant results.

Sergio Casciaro, the CEO and founder of Echolight, expressed confidence in Mike’s capabilities: "Mike is an award-winning leader who has consistently delivered impressive results throughout his career. His immediate focus will be on evaluating our current operations and implementing necessary changes across the region to ensure strategic alignment and effective execution."

Enhancing Business Growth

In his new role, Mike Yuja will be responsible for devising and executing strategies that are geared toward better profitability and growth within the North American market. This includes not only the creation of a robust sales force but also overseeing full profit and loss management. He replaces Tom McLaughlin, who is retiring, and will focus on continuing to build upon the strategies established during McLaughlin's tenure.

Echolight's innovative REMS (Radiofrequency Echographic Multi Spectometry) technology represents a standout advancement in assessing bone density. Unlike traditional x-ray scans that utilize radiation, REMS conducts bone assessments through a simple ultrasound scan, making it a safer option for patients. Mike Yuja remarked, "I am excited to build on the foundation laid by Tom McLaughlin and help position the company for a period of explosive growth."

Strengthening Market Position

Since its establishment in Italy, Echolight has shown remarkable growth, opening offices in the United States in 2020 and expanding its distributor network to over 40 across the globe. With hundreds of satisfied customers, the company has gained recognition for its innovative approach to bone health and personalized medicine.

Echolight holds numerous important certifications, including ISO certifications and FDA approvals, which underscore its commitment to quality and excellence in the medical field. The company aims to leverage Mike Yuja’s leadership to further its mission of introducing cutting-edge solutions that significantly contribute to human well-being.

In summary, Mike Yuja’s appointment as Echolight's Chief Commercial Officer is set to propel the company to new heights as it continues to advance in the competitive landscape of medical innovation. With a dynamic leadership team and a commitment to groundbreaking technology, Echolight is poised for an exciting future in bone health management.